Clinical Trial Update: IVIg for Demyelination in Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating intravenous immunoglobulin (IVIg) for demyelinating peripheral neuropathies in diabetes mellitus, including CIDP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Inflammatory Demyelinating Polyneuropathy
• Peripheral Neuropathy

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: University of Toronto | Conditions: Peripheral Neuropathy, Diabetes Mellitus | Phase 4 | Status: UNKNOWN